Current Drug Targets - Inflammation & Allergy
Title: Editorial [Hot Topic: The Kinetics and Profiles of Inflammatory Cells During Inflammatory and Allergic Responses (Guest Editor: Tsuyoshi Kasama)]
Volume: 4 Issue: 3
Author(s): Tsuyoshi Kasama
Affiliation:
Export Options
About this article
Cite this article as:
Kasama Tsuyoshi, Editorial [Hot Topic: The Kinetics and Profiles of Inflammatory Cells During Inflammatory and Allergic Responses (Guest Editor: Tsuyoshi Kasama)], Current Drug Targets - Inflammation & Allergy 2005; 4 (3) . https://dx.doi.org/10.2174/1568010054022105
DOI https://dx.doi.org/10.2174/1568010054022105 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design Recent Development in the Field of Dual COX / 5-LOX Inhibitors
Mini-Reviews in Medicinal Chemistry Analysis of Current Antifungal Agents and Their Targets within the Pneumocystis carinii Genome
Current Drug Targets The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine
Current Molecular Medicine Tumor-Associated Macrophages as Potential Targets for Anti-Cancer Activity of Marine Invertebrate-Derived Compounds
Current Pharmaceutical Design Uveitis in Rheumatic Diseases
Current Rheumatology Reviews Aminophosphonic Acids of Potential Medical Importance
Current Medicinal Chemistry - Anti-Cancer Agents miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
Current Gene Therapy Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Combinatorial Chemistry & High Throughput Screening Th17 Cells in Airway Diseases
Current Molecular Medicine Update on the Management of Systemic Lupus Erythematosus from a Pediatric Nephrology Perspective
Current Rheumatology Reviews Upregulation of Connexin-43 is Critical for Irradiation-induced Neuroinflammation
CNS & Neurological Disorders - Drug Targets Patent Selections :
Recent Patents on Biomarkers Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology Polyunsaturated Fatty Acids and their Related Enzymes in Postmortem Brain Tissues of Patients with Psychiatric Disorders
Current Psychopharmacology Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
Current Pharmaceutical Design Therapeutic Moderate Hypothermia and Fever
Current Pharmaceutical Design The Expanding Role of APRIL in Cancer and Immunity
Current Molecular Medicine Can we Target the Chemokine Network for Cancer Therapeutics?
Current Cancer Drug Targets Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets